J.M. Reimund

Biochemistry, Genetics and Molecular Biology · Life Sciences

17h-index1.7kcitations60works0.02yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Inflammatory Bowel Disease(23), Microscopic Colitis(13), Clinical Nutrition and Gastroenterology(9), Liver Diseases and Immunity(4), Helicobacter pylori-related gastroenterology studies(3)

Publications59 total

P207 COVID-19: a prevalence rate two times lower than that of the general population in French patients with Inflammatory Bowel Disease treated with intravenous biologic agents
Journal of Crohn s and Colitis·2022Open Access
Patients’ real-world experience with inflammatory bowel disease: A cross-sectional survey in tertiary care centres from the GETAID group
Digestive and Liver Disease·2020· 6 citedOpen Access
Early Transmural Response Assessed Using Magnetic Resonance Imaging Could Predict Sustained Clinical Remission and Prevent Bowel Damage in Patients with Crohn’s Disease Treated with Anti-Tumour Necrosis Factor Therapy
Journal of Crohn s and Colitis·2020· 41 cited
P559 Effect of vedolizumab and ustekinumab on articular manifestations in patients with inflammatory bowel disease refractory or intolerant to anti-TNF therapy: An observational prospective study
Journal of Crohn s and Colitis·2020· 1 citedOpen Access
P248 Validation of IBD-disk for the assessment of daily-life burden of patients with inflammatory bowel disease
Journal of Crohn s and Colitis·2020· 6 citedOpen Access
P347 Vedolizumab for primary sclerosing cholangitis associated with inflammatory bowel disease: A multicentre cohort study from the GETAID
Journal of Crohn s and Colitis·2018· 4 citedOpen Access
Recommandations du CDU–HGE, du CNU d’HGE et de la SFED sur la formation en endoscopie digestive
Acta Endoscopica·2016
Infliximab Reduces Endoscopic, but Not Clinical, Recurrence of Crohn’s Disease After Ileocolonic Resection
Gastroenterology·2016· 320 citedOpen Access
Erratum to: Occlusion intestinale en zone d’endémie : penser aussi à la tuberculose
Acta Endoscopica·2016
Enteropathogenic E.coli sustains iodoacetamide-induced ulcerative colitis-like colitis in rats: Modulation of IL-1β, IL-6, TNF-α, cox-2, and apoptosis
Scopus·2012· 1 citedOpen Access
A fulminant colitis index greater or equal to 8 is not predictive of colectomy risk in infliximab-treated moderate-to-severe ulcerative colitis attacks
Gastroentérologie Clinique et Biologique·2010· 2 cited
Can cetuximab specific IgE antibodies predict cetuximab-induced anaphylaxis?
Journal of Clinical Oncology·2010
Increase in circulating microparticles in inflammatory bowel disease patients induces vascular alterations by a subtle unbalance between nitrosative and oxidative stresses and metabolites from COX-2
HAL (Le Centre pour la Communication Scientifique Directe)·2010
Iconography : Pancreatic cancer: Incidence, treatment and survival trends – 1175 cases in Calvados (France) from 1978 to 2002
2009
Pancreatic cancer: Incidence, treatment and survival trends – 1175 cases in Calvados (France) from 1978 to 2002
Gastroentérologie Clinique et Biologique·2009· 26 cited
6124 Cetuximab specific IgE antibodies can predict cetuximab-induced anaphylaxis
European Journal of Cancer Supplements·2009
Colon cancer in inflammatory bowel disease: recent trends, questions and answers
Gastroentérologie Clinique et Biologique·2009· 35 cited
CO.77 In vitro, les ligands du récepteur beta aux estrogènes ont un effet pro-apoptotique dans des lignées cellulaires de cancer colique
Gastroentérologie Clinique et Biologique·2009
P.32 Efficacité symptomatique d’un aliment lacté fermenté par une souche probiotique, Lactobacillus paracasei, au cours du syndrome de l’intestin irritable (SII). Résultats d’une étude contrôlée multicentrique en groupes parallèles
Gastroentérologie Clinique et Biologique·2009
P.158 Dans la « vraie vie », l’infliximab est aussi efficace dans les formes luminales prédominantes que dans les formes fistulisantes prédominantes de la maladie de Crohn (MC) : une étude retrospective
Gastroentérologie Clinique et Biologique·2009
page 1 of 3Next →

Frequent Co-authors

Bernard Duclos(23), René Baumann(16), Stéphane Nancey(7), David Laharie(6), Stéphanie Viennot(6), Christian D. Muller(6), Guillaume Bouguen(6), Matthieu Allez(5), Laurent Peyrin‐Biroulet(5), Mélanie Serrero(5), Guillaume Savoye(5), Denis Franchimont(4), Serge Dumont(4), Philippe Poindron(4), Yves Arondel(4), C. Koehl(4), Anthony Buisson(4), Maria Nachury(4), Yoram Bouhnik(4), Lucine Vuitton(4)